Fintel reports that on March 31, 2025, BTIG upgraded their outlook for Progyny (NasdaqGS:PGNY) from Neutral to Buy. Analyst ...

BTIG upgraded financial services company Capital One Financial Corporation (COF) to Buy from Hold with a price target of $208 ...

BTIG says Rocket Companies (RKT) is acquiring Mr. Cooper (COOP) in an all-stock deal valuing Cooper at roughly $143 ore share, plus a $2 cash ...

The S&P 500's (SP500) recent breakdown below key technical levels suggests the market’s counter-trend rally may be over, said ...

BTIG analysts highlighted a historical trend suggesting a potential rebound for the S&P 500 (SPX) in April following a ...

Friday’s stock market slide will likely cement the S&P 500 and Nasdaq Composite’s seventh weekly decline in nine weeks. The S ...

CrowdStrike (CRWD) was upgraded from Neutral to Buy by BTIG, and maintains a $431 price target on the stock. Market Domination hosts Julie Hyman and Josh Lipton break down BTIG's reasons for the ...

Investing.com -- BTIG downgraded Ally Financial (NYSE:ALLY) Inc to Sell from Neutral with a $30 target saying a challenging macroeconomic condition and increased competition in the auto lending ...

Shares of CrowdStrike ( CRWD 3.34%) surged higher on Monday. The company's stock had gained 3.7% as of 10:50 a.m. ET but had ...

U.S. equities mostly gained at midday on continued optimism about tariffs and a solid increase in home prices.

Ovid Therapeutics (NASDAQ:OVID – Get Free Report) had its price objective cut by BTIG Research from $5.00 to $4.00 in a ...

chief market technician at financial-services firm BTIG. In a March 28 note to clients, Krinsky pointed to the S&P 500's (SP500) inability to hold the 5,670 level, a gap that had been a key ...